Bristol-Myers Squibb Company
BMY
$56.45
$0.781.40%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.10% | 2.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.10% | 2.29% | |||
| Cost of Revenue | -2.82% | 5.89% | |||
| Gross Profit | -10.16% | 0.95% | |||
| SG&A Expenses | -22.86% | 16.72% | |||
| Depreciation & Amortization | -47.09% | -0.60% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.34% | 7.38% | |||
| Operating Income | 7.81% | -8.74% | |||
| Income Before Tax | 120.34% | -52.79% | |||
| Income Tax Expenses | 46.09% | -58.22% | |||
| Earnings from Continuing Operations | 146.59% | -50.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -200.00% | -83.33% | |||
| Net Income | 146.27% | -50.61% | |||
| EBIT | 7.81% | -8.74% | |||
| EBITDA | -3.04% | -7.40% | |||
| EPS Basic | 146.02% | -50.61% | |||
| Normalized Basic EPS | -5.60% | -5.18% | |||
| EPS Diluted | 147.40% | -50.97% | |||
| Normalized Diluted EPS | -5.79% | -5.27% | |||
| Average Basic Shares Outstanding | 0.10% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.10% | |||
| Dividend Per Share | 0.00% | 1.61% | |||
| Payout Ratio | -0.59% | 1.02% | |||